MoonLake CEO Jorge Santos da Silva sells $2.05 million of common shares
MLTX•CEO share sales disclosed
MoonLake Immunotherapeutics CEO Jorge Santos da Silva sold 102,225 Class A ordinary shares on July 9-10.
- Sales were priced at $20.01 per share on July 9 and $20.02 per share on July 10.
- Direct holdings fell to 2,774,893 Class A ordinary shares.
